Cargando…
Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease
BACKGROUND: This study aimed to explore clinical value and expression of Homer 1, S-adenosyl-l-homocysteine (SAH), homocysteine (Hcy), fibroblast growth factors (FGF) 23 in coronary heart disease (CHD). METHODS: From March 2020 to April 2021, a total of 137 patients with CHD and 138 healthy subjects...
Autores principales: | Zhang, Zhixin, Wang, Lin, Zhan, Yu, Xie, Cui, Xiang, Yang, Chen, Dan, Wu, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097103/ https://www.ncbi.nlm.nih.gov/pubmed/35546659 http://dx.doi.org/10.1186/s12872-022-02554-4 |
Ejemplares similares
-
Structural insights into the reaction mechanism of S-adenosyl-L-homocysteine hydrolase
por: Kusakabe, Yoshio, et al.
Publicado: (2015) -
Homocysteine as a Risk Factor for Atherosclerosis: Is Its Conversion to S-Adenosyl-L-Homocysteine the Key to Deregulated Lipid Metabolism?
por: Tehlivets, Oksana
Publicado: (2011) -
S‐adenosyl‐L‐homocysteine extends lifespan through methionine restriction effects
por: Ogawa, Takafumi, et al.
Publicado: (2022) -
S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system
por: Tehlivets, Oksana, et al.
Publicado: (2013) -
S-Adenosyl-L-Homocysteine Hydrolase Inhibition by a Synthetic Nicotinamide Cofactor Biomimetic
por: Kailing, Lyn L., et al.
Publicado: (2018)